Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): Increased invasiveness may contribute to poor prognosis

Feng Ji Xu, Sharon Stack, Cinda Boyer, Kathy O'Briant, Regina Whitaker, Gordon B. Mills, Yin Hua Yu, Robert C. Bast

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): Increased invasiveness may contribute to poor prognosis'. Together they form a unique fingerprint.

Medicine & Life Sciences